Marzia Stabile

Dr. Marzia Stabile

orcid

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
4 September 2019 in Veterinary Sciences
Verified
Journal Article
Open access
PDF file
Marzia StabileMarzia Stabile
Marzia Stabile
RSRossella Samarelli
Rossella Samarelli
PTPaolo Trerotoli
Paolo Trerotoli
LFLaura Fracassi
Laura Fracassi
LLLuca Lacitignola
Luca Lacitignola
Francesco  StaffieriFrancesco Staffieri
Francesco Staffieri
Osteoarthritis (OA) is a chronic disease that requires a multimodal therapeutic approach. The aim of this study was to evaluate the effects of undenatured type II collagen (UC-II) as compared to robenacoxib in dogs affected by OA. Our hypothesis was that the two compounds would be similar (non-inferiority) in improving mobility. To test this hypothesis, a complete orthopedic examination, x-ray and the Liverpool Osteoarthritis in Dogs (LOAD) survey were performed in dogs affected by OA before and after the treatments. The study was designed as a clinical, randomized, controlled and prospective study. Sixty client-owned dogs were randomized in the R group (n = 30, robenacoxib 1 mg/kg/day for 30 days) and in the UC-II group (n = 30, UC-II 1 tablet/day for 30 days). Thirty days after the beginning of the treatment (T30), the dogs were reassessed for the LOAD, MOBILITY and CLINICAL scores. Based on the data obtained from the study, a significant reduction in LOAD and MOBILITY scores was recorded between T0 and T30 with a similar magnitude among the two groups (R = 31.5%, p < 0.001; UC-II = 32.7%, p = 0.013). The results of this study showed that UC-II and robenacoxib were able to similarly improve mobility of dogs affected by OA.

16 November 2022 in Scientific Reports
Verified
Journal Article
Open access
PDF file
Marzia StabileMarzia Stabile
Marzia Stabile
CGChiara Roberta Girelli
Chiara Roberta Girelli
LLLuca Lacitignola
Luca Lacitignola
RSRossella Samarelli
Rossella Samarelli
ACAntonio Crovace
Antonio Crovace
FSFrancesco Staffieri
Francesco Staffieri
The aim of the study was to compare the metabolomic synovial fluid (SF) profile of dogs affected by spontaneous osteoarthritis (OA) and supplemented with undenatured type II collagen (UC-II), with that of healthy control dogs. Client-owned dogs were enrolled in the study and randomized in two different groups, based on the presence/absence of OA (OA group and OA-free group). All dogs were clinically evaluated and underwent SF sampling for1H-Nuclear Magnetic Resonance spectroscopy (1H-NMR) analysis at time of presentation. All dogs included in OA group were supplemented with UC-II orally administered for 30 days. After this period, they were reassessed (OA-T30). The differences in the1H-NMR metabolic SFs profiles between groups (OA-free, OA-T0 and OA-T30) were studied. The multivariate statistical analysis performed on SFs under different conditions (OA-T0 vs OA-T30 SFs; OA-T0 vs OA-free SFs and OA-T30 vs OA-free SFs) gave models with excellent goodness of fit and predictive parameters, revealed by a marked separation between groups. β-Hydroxybutyrate was identified as a characteristic compound of osteoarthritic joints, showing the important role of fat metabolism during OA. The absence of β-hydroxybutyrate after UC-II supplementation suggests the supplement’s effectiveness in rebalancing the metabolism inside the joint. The unexpectedly high level of lactate in the OA-free group suggests that lactate could not be considered a good marker for OA. These results prove that1H-NMR-based metabolomic analysis is a valid tool to study and monitor OA and that UC-II improves clinical symptoms and the SF metabolic profile in OA dogs.

10 July 2022 in Research in Veterinary Science
Verified
Journal Article
Closed access
Marzia StabileMarzia Stabile
Marzia Stabile
LLLuca Lacitignola
Luca Lacitignola
RSRossella Samarelli
Rossella Samarelli
MFMarco Fiorentino
Marco Fiorentino
ACANTONIO CROVACE
ANTONIO CROVACE
Francesco  StaffieriFrancesco Staffieri
Francesco Staffieri

1 April 2020
Verified
Journal Article
Closed access
Caterina Di BellaCaterina Di Bella
Caterina Di Bella
DSDespoina Skouropoulou
Despoina Skouropoulou
Marzia StabileMarzia Stabile
Marzia Stabile
CMCosmin Muresan
Cosmin Muresan
SGSalvatore Grasso
Salvatore Grasso
Francesco  StaffieriFrancesco Staffieri
Francesco Staffieri

11 February 2021 in Veterinary Sciences
Verified
Journal Article
Open access
PDF file
DSDespoina Skouropoulou
Despoina Skouropoulou
LLLuca Lacitignola
Luca Lacitignola
Caterina Di BellaCaterina Di Bella
Caterina Di Bella
Marzia StabileMarzia Stabile
Marzia Stabile
CAClaudia Acquafredda
Claudia Acquafredda
Francesco  StaffieriFrancesco Staffieri
Francesco Staffieri
The aim of this study was to evaluate the incidence of fluid responsiveness (FR) to a fluid challenge (FC) in normotensive dogs under anaesthesia. The accuracy of pulse pressure variation (PPV), systolic pressure variation (SPV), stroke volume variation (SVV), and plethysmographic variability index (PVI) for predicting FR was also evaluated. Dogs were anaesthetised with methadone, propofol, and inhaled isoflurane in oxygen, under volume-controlled mechanical ventilation. FC was performed by the administration of 5 mL/kg of Ringer’s lactate within 5 min. Cardiac index (CI; L/min/m2), PPV, (%), SVV (%), SPV (%), and PVI (%) were registered before and after FC. Data were analysed with ANOVA and ROC tests (p < 0.05). Fluid responsiveness was defined as 15% increase in CI. Eighty dogs completed the study. Fifty (62.5%) were responders and 30 (37.5%) were nonresponders. The PPV, PVI, SPV, and SVV cut-off values (AUC, p) for discriminating responders from nonresponders were PPV >13.8% (0.979, 14% (0.956, 4.1% (0.793, 14.7% (0.729, <0.001), respectively. Up to 62.5% of normotensive dogs under inhalant anaesthesia may be fluid responders. PPV and PVI have better diagnostic accuracy to predict FR, compared to SPV and SVV.

13 January 2023 in Frontiers in Veterinary Science
Verified
Journal Article
Open access
Marzia StabileMarzia Stabile
Marzia Stabile
LLLuca Lacitignola
Luca Lacitignola
CAClaudia Acquafredda
Claudia Acquafredda
ASAnnalaura Scardia
Annalaura Scardia
ACAntonio Crovace
Antonio Crovace
Francesco  StaffieriFrancesco Staffieri
Francesco Staffieri
Objectives: This study investigated the effects of 1 μg/kg/h intravenous constant rate infusion (CRI) of dexmedetomidine on the sensory and motor blockade for femoral and sciatic nerve blocks in dogs undergoing stifle surgery.Materials and methods: Client-owned dogs referred for stifle surgery were enrolled in this prospective, randomized, blinded study. Dogs were pre-medicated with acepromazine (0.005–0.01 mg/kg intramuscularly, IM); anesthesia was induced with propofol intravenously and maintained with isoflurane in a mixture of air and oxygen. Electrolocation-guided sciatic and femoral nerve blocks with lidocaine 2% (0.15 mL/kg) were performed using the parasacral and lateral pre-iliac approaches, respectively. After performing local block, a systemic infusion of saline solution (group C) or dexmedetomidine (group D) was started at a CRI at 1 ml/kg/h and continued until the end of surgery. Dexmedetomidine was infused at a dose of 1 μg/kg/h. Respiratory and hemodynamic variables were recorded during surgery. Sensory and motor blockade was evaluated by response to pinching the skin innervated by the sciatic/femoral nerves, with forceps and by observing the dogs' ability to walk and testing proprioception at 30, 60, 120, 180, and 240 min after extubation. Analgesia was monitored with SF-GCPS. Methadone IM was administered as rescue analgesia. Intraoperative data were analyzed by analysis of variance, while postoperative data were analyzed by the independent two-tailedt-test and a Kaplan–Meier test (p< 0.05).Results: Twenty dogs were included in this study (10/group). A significant difference in the recovery of sensory nerve function was observed between the groups. The mean durations of the sensory blockade for femoral and sciatic nerves, respectively, was longer (p< 0.001) for group D [168 (146–191, 95% CI), 161 (143–179, 95% CI) min] than in group C [120 (96.1–144, 95% CI), 116 (90.9–142, 95% CI]. No differences in the recovery of patellar and tibial reflexes, proprioceptive function, and ability to walk were found among groups. The overall postoperative rescue analgesia requirement was significantly different (p= 0.019) between groups, with an incidence of 5/10 (50%) dogs in group D and 10/10 (100%) dogs in group C.Conclusion: Dexmedetomidine administered as a CRI (1 μg/kg/h) combined with local lidocaine increases the duration of the sensory component of the sciatic and femoral nerve blocks and reduces the requirement for additional analgesia during the immediate postoperative hours.